TLIS INVESTOR ALERT: Hagens Berman, National Trial

SAN FRANCISCO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to...

Related Keywords

Hagens Berman ,Reed Kathrein ,Twitter ,Talis Biomedical Corporation ,Plaintiff Deadline ,Biomedical Corporation ,Securities Class Action ,Talis One ,Disease Control ,Talis Biomedical ,Hagens Berman Sobol Shapiro Llp ,Lis Class Action ,Lis Fraud ,Lis Investor ,Lis Investor Fraud ,Lis Lawsuit ,Lis Securities Fraud ,Lis Stock ,Lis Securities ,Lass Action ,